Cargando…

Antibody Assay and Anti-Inflammatory Function Evaluation of Therapeutic Potential of Different Intravenous Immunoglobulins for Alzheimer’s Disease

Alzheimer’s disease (AD) is a common neurodegenerative disease that currently has no known cure. Intravenous immunoglobulin (IVIG), which contains AD-related antibodies and has anti-inflammatory properties, has shown potential as a treatment for AD. However, the efficacy of clinical trials involving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fei, Zhangcheng, Pei, Renjun, Pan, Bo, Ye, Shengliang, Zhang, Rong, Ma, Li, Wang, Zongkui, Li, Changqing, Du, Xi, Cao, Haijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058273/ https://www.ncbi.nlm.nih.gov/pubmed/36982622 http://dx.doi.org/10.3390/ijms24065549

Ejemplares similares

Efficacy and safety of blood derivatives therapy in Alzheimer’s disease: a systematic review and meta-analysis
por: Fei, Zhangcheng, et al.
Publicado: (2022)

Proteomics profiles of blood glucose-related proteins involved in a Chinese longevity cohort
por: Zhang, Rong, et al.
Publicado: (2022)

Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Fei, Zhangcheng, et al.
Publicado: (2022)

Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population
por: Wang, Zongkui, et al.
Publicado: (2017)

GDF11 Regulates PC12 Neural Stem Cells via ALK5-Dependent PI3K-Akt Signaling Pathway
por: Wang, Zongkui, et al.
Publicado: (2022)

GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway
por: Wang, Zongkui, et al.
Publicado: (2018)

Analysis of influencing factors of serum total protein and serum calcium content in plasma donors
por: Liu, Bin, et al.
Publicado: (2022)

Blood Service in a Region of China’s Qinghai–Tibetan Plateau
por: Sun, Pan, et al.
Publicado: (2023)

Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives
por: Sun, Pan, et al.
Publicado: (2023)

Intravenous immunoglobulin and Alzheimer’s disease: what now?
por: Loeffler, David A
Publicado: (2013)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

Plasma proteomic and autoantibody profiles reveal the proteomic characteristics involved in longevity families in Bama, China
por: Ye, Shengliang, et al.
Publicado: (2019)

Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins
por: Kayed, Rakez, et al.
Publicado: (2011)

Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2014)

Intravenous immunoglobulin for the treatment of Alzheimer’s disease: current evidence and considerations
por: Schindowski, Christina, et al.
Publicado: (2014)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2015)

Antifungal antibodies present in intravenous immunoglobulin derived from China
por: Wang, Yanfang, et al.
Publicado: (2023)

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)

Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
por: Jacob, Saiju, et al.
Publicado: (2009)

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
por: Dourmishev, Lyubomir A., et al.
Publicado: (2016)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme
por: Wiatr, Marie, et al.
Publicado: (2019)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin
por: Sali, Aggeliki D, et al.
Publicado: (2015)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
por: Mahdi-Rogers, Mohamed, et al.
Publicado: (2010)

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2016)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin
por: Bae, Sangmee Sharon, et al.
Publicado: (2023)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study
por: Chen, Yan, et al.
Publicado: (2022)

Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin
por: Parker, Simon, et al.
Publicado: (2014)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
por: Rogier, Thomas, et al.
Publicado: (2020)

The quality changes in fresh frozen plasma of the blood donors at high altitude
por: Wang, Zongkui, et al.
Publicado: (2017)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
por: Li, Tao-Ran, et al.
Publicado: (2020)

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Puli, Lakshman, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ja4tcjji3l4h0jpsdv9bqm7tn0